Thursday, April 30, 2026
spot_img
HomeIndustries

Industries

Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines

Exopharm Limited has been granted US patent US 11202805 for its LEAP exosome purification technology. This patent positions Exopharm as a global leader in...

CDC Publishes AXIM® Biotechnologies-Sponsored Study on COVID-19 Neutralizing Antibodies

AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting COVID-19 diagnostics, oncological research, and dry eye...

Sandoz submits Marketing Authorization Application for proposed biosimilar trastuzumab to EMA

Sandoz, a global leader in generic and biosimilar medicines, announced that it has submitted a Marketing Authorization Application for a proposed biosimilar trastuzumab (150...

RAFA Enters into Negotiations with JINR for Ultra-Cutting Edge Nuclear Research

Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is currently negotiating with the Joint Institute for Nuclear Research (JINR), an international intergovernmental scientific organization established by eleven founding...

MedMira Announces VYRA CoV2Flu and Additional Regulatory Opportunities

MedMira Inc. announces the expansion of its VYRA product line by launching its VYRA CoV2Flu Rapid Antigen Rapid Test (VYRA™ CoV2Flu). Based on MedMira’s...

Hot Topics

spot_img